Columbia Wanger Asset Management’s Entellus Medical, Inc. Common Stock ENTL Stock Holding History

Columbia Wanger Asset Management’s Portfolio ENTL Stock Details ENTL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	$9.74M	Buy	+399,500	New	+$7.68M	0.15%	181

Other funds holding ENTL

Essex Woodlands Management The Woodlands, Texas $254M AUM 4.59% 1-Year Est. Return

SV Health Investors Boston, Massachusetts $32.3M AUM 20.15% 1-Year Est. Return

Kohlberg Kravis Roberts & Co New York $5.35B AUM 63.01% 1-Year Est. Return

Sand Grove Capital Management London, United Kingdom $444M AUM 131.11% 1-Year Est. Return

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Archon Capital Management Seattle, Washington $177M AUM 108.05% 1-Year Est. Return

Aisling Capital New York $45.3M AUM 15.24% 1-Year Est. Return

Columbia Wanger Asset Management's ENTL Position: Q4 2017 in Review

Columbia Wanger Asset Management opened a new position in Entellus Medical, Inc. Common Stock (ENTL) in Q4 2017: 399,500 shares worth $9.74M. The stake represents 0.15% of the portfolio and ranks #181 among its holdings.

83 funds tracked by Wall St. Rank hold ENTL as of Q4 2017.

Columbia Wanger Asset Management held 399,500 shares of Entellus Medical, Inc. Common Stock worth $9.74M as of Q4 2017.
Entellus Medical, Inc. Common Stock was a new Columbia Wanger Asset Management position in Q4 2017.
Entellus Medical, Inc. Common Stock made up 0.15% of Columbia Wanger Asset Management's portfolio in Q4 2017, its #181 holding.
83 funds tracked by Wall St. Rank held Entellus Medical, Inc. Common Stock as of Q4 2017.

Based on Columbia Wanger Asset Management's 13F filing for Q4 2017, filed 13 Feb 2018.